Jerry S. Lanchbury - 07 Jul 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Issuer symbol
MYGN
Transactions as of
07 Jul 2021
Net transactions value
-$186,821
Form type
4
Filing time
08 Jul 2021, 17:50:44 UTC
Previous filing
30 Jun 2021
Next filing
12 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $805,932 +30,424 +13% $26.49 262,974 07 Jul 2021 Direct F1
transaction MYGN Common Stock Sale $982,391 -30,424 -12% $32.29 232,550 07 Jul 2021 Direct F1
transaction MYGN Common Stock Options Exercise $49,907 +1,884 +0.81% $26.49 234,434 07 Jul 2021 Direct F1
transaction MYGN Common Stock Sale $60,269 -1,884 -0.8% $31.99 232,550 07 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Incentive Stock Option (right to buy) Options Exercise $0 -1,884 -100% $0.000000* 0 07 Jul 2021 Common Stock 1,884 $26.49 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30,424 -18% $0.000000 141,828 07 Jul 2021 Common Stock 30,424 $26.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.